IGC Pharma, Inc. (IGC): Total Assets

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$8.75M
As of 2025-03-31
-31.2%
3-year compound annual growth
-21.3%
5-year compound annual growth
-8.1%
10-year compound annual growth
$35.87M2011-03-31: $18.16M2012-03-31: $25.26M2013-03-31: $19.25M2014-03-31: $17.73M2015-03-31: $20.33M2016-03-31: $18.86M2017-03-31: $11.28M2018-03-31: $10.85M2019-03-31: $34.47M2020-03-31: $28.98M2021-03-31: $35.87M2022-03-31: $26.83M2023-03-31: $17.18M2024-03-31: $9.90M2025-03-31: $8.75M$8.75M
2011-03-31 Total Assets (USD) 2025-03-31
Period endedTotal AssetsChange YoYSource filing
2025-03-31$8.75M-11.7%2025-06-27, Balance as of period end
2024-03-31$9.90M-42.4%2025-06-27, Balance as of period end
2023-03-31$17.18M-36.0%2024-06-24, Balance as of period end
2022-03-31$26.83M-25.2%2023-07-07, Balance as of period end
2021-03-31$35.87M+23.7%2022-06-23, Balance as of period end
2020-03-31$28.98M-15.9%2021-06-14, Balance as of period end
2019-03-31$34.47M+217.6%2020-07-13, Balance as of period end
2018-03-31$10.85M-3.8%2019-06-14, Balance as of period end
2017-03-31$11.28M-40.2%2018-06-21, Balance as of period end
2016-03-31$18.86M-7.2%2017-07-14, Balance as of period end
2015-03-31$20.33M+14.6%2016-07-14, Balance as of period end
2014-03-31$17.73M-7.9%2015-07-14, Balance as of period end
2013-03-31$19.25M-23.8%2014-07-15, Balance as of period end
2012-03-31$25.26M+39.1%2014-07-15, Balance as of period end
2011-03-31$18.16Mn/a2012-07-16, Balance as of period end